Laura Albini

519 total citations
16 papers, 344 citations indexed

About

Laura Albini is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, Laura Albini has authored 16 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 9 papers in Emergency Medicine and 6 papers in Virology. Recurrent topics in Laura Albini's work include HIV-related health complications and treatments (9 papers), HIV/AIDS drug development and treatment (9 papers) and HIV Research and Treatment (6 papers). Laura Albini is often cited by papers focused on HIV-related health complications and treatments (9 papers), HIV/AIDS drug development and treatment (9 papers) and HIV Research and Treatment (6 papers). Laura Albini collaborates with scholars based in Italy, Japan and United States. Laura Albini's co-authors include Eugenia Quirós-Roldán, D Gotti, Emanuele Focà, Alessandra Calabresi, Nicoletta Ladisa, Francesco Donato, Gioacchino Angarano, Carlo Torti, Davide Motta and Giuseppe Lapadula and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Laura Albini

15 papers receiving 338 citations

Peers

Countries citing papers authored by Laura Albini

Since Specialization

Citations

This map shows the geographic impact of Laura Albini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Albini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Albini more than expected).

Fields of papers citing papers by Laura Albini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Albini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Albini. The network helps show where Laura Albini may publish in the future.

Co-authorship network of co-authors of Laura Albini

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Albini. A scholar is included among the top collaborators of Laura Albini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Albini. Laura Albini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Effectiveness, safety, and patient-reported outcomes of bictegravir/emtricitabine/tenofovir alafenamide in routine clinical care in Italy: 12-Month results from the BICSTaR cohort 2025 ·International Journal of STD & AIDS ·(unknown), Giulia Marchetti, Vincenzo Esposito, Stefano Rusconi, (unknown), Eugenia Quirós-Roldán, (unknown), (unknown), Massimo Andreoni, Andrea Marongiu, Tali Cassidy, David Thorpe, Laura Albini, (unknown), Gabriele Forcina, Giovanni Di Perri	1
2	Neuropsychiatric adverse events in people with HIV initiating a new integrase strand transfer inhibitor-based regimen in Italy: findings from the NEURO-INSTI study 2025 ·BMC Infectious Diseases ·Nicola Squillace, Elena Ricci, (unknown), Gabriele Forcina, Laura Albini, Barbara Menzaghi, Giuseppe Vittorio De Socio, Stefania Piconi, Paolo Maggi, Giordano Madeddu, Giovanni Francesco Pellicanò, Eleonora Sarchi, Benedetto Maurizio Celesia, Filippo Lagi, (unknown), Antonio Di Biagio, Paolo Bonfanti	0
3	Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study 2015 ·BMC Public Health ·(unknown), Elena Raffetti, Laura Albini, D Gotti, Daniela Segala, (unknown), Elisa Di Filippo, Annalisa Saracino, Nicoletta Ladisa, Giuseppe Lapadula, (unknown), Filippo Castelnuovo, Salvatore Casari, Massimiliano Fabbiani, Piera Pierotti, Francesco Donato, Eugenia Quirós-Roldán	28
4	Survival in HIV-Infected Patients after a Cancer Diagnosis in the cART Era: Results of an Italian Multicenter Study 2014 ·PLoS ONE ·D Gotti, Elena Raffetti, Laura Albini, Laura Sighinolfi, (unknown), Elisa Di Filippo, Nicoletta Ladisa, Gioacchino Angarano, Giuseppe Lapadula, Angelo Pan, Anna Degli Esposti, Massimiliano Fabbiani, Emanuele Focà, Alfredo Scalzini, Francesco Donato, Eugenia Quirós-Roldán, (unknown)	40
5	Burden of Non-AIDS-Defining and Non-Virus-Related Cancers Among HIV-Infected Patients in the Combined Antiretroviral Therapy Era 2013 ·AIDS Research and Human Retroviruses ·Laura Albini, Alessandra Calabresi, D Gotti, Alice Ferraresi, Andrea Festa, Francesco Donato, Michele Magoni, Francesco Castelli, Eugenia Quirós-Roldán	31
6	Clinical Characteristics, Incidence, and Risk Factors of HIV-Related Hodgkin Lymphoma in the Era of Combination Antiretroviral Therapy 2013 ·AIDS Patient Care and STDs ·D Gotti, (unknown), Alessandra Calabresi, Alice Ferraresi, Laura Albini, Francesco Donato, Francesco Castelli, Alfredo Scalzini, Eugenia Quirós-Roldán	17
7	Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz 2012 ·BMC Infectious Diseases ·Emanuele Focà, Davide Motta, Marco Borderi, D Gotti, Laura Albini, Alessandra Calabresi, Ilaria Izzo, Rita Bellagamba, Pasquale Narciso, Laura Sighinolfi, (unknown), Davide Gibellini, Eugenia Quirós-Roldán, (unknown), Bruno Mario Cesana, Maria Carla Re, Carlo Torti	35
8	Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010 2012 ·Clinical Microbiology and Infection ·Manuela Colafigli, Carlo Torti, Enrico Maria Trecarichi, Laura Albini, A. Rosi, Valeria Micheli, N. Manca, Giovanni Penco, Bianca Bruzzone, Grazia Punzi, Paola Corsi, Giustino Parruti, (unknown), Laura Monno, (unknown), Roberto Cauda, Simona Di Giambenedetto	23
9	Kidney transplantation in HIV‐positive patients: a report of 14 cases 2012 ·Journal of the International AIDS Society ·Salvatore Casari, Nicola Bossini, Laura Albini, (unknown), Francesca Valerio, Ilaria Izzo, Silvia Costarelli, Silvio Sandrini, Giovanni Cancarini, Francesco Castelli	2
10	Increase in Standard Cholesterol and Large HDL Particle Subclasses in Antiretroviral-Naïve Patients Prescribed Efavirenz Compared to Atazanavir/Ritonavir 2012 ·HIV Clinical Trials ·D Gotti, Bruno Mario Cesana, Laura Albini, Alessandra Calabresi, Ilaria Izzo, Emanuele Focà, Davide Motta, Rita Bellagamba, (unknown), Pasquale Narciso, (unknown), Paolo Maggi, (unknown), Eugenia Quirós-Roldán, Giovanni Guaraldi, Carlo Torti	23
11	Impact of detectable human cytomegalovirus DNAemia on viro-immunological effectiveness of HAART in HIV-infected patients naive to antiretroviral therapy. 2012 ·PubMed ·Emanuele Focà, Davide Motta, (unknown), (unknown), D Gotti, Laura Albini, Eugenia Quirós-Roldán, Carlo Torti, N. Manca	2
12	Cryptogenic Liver Diseases: Sailing by Sight from HIV Co-Infection with Hepatitis Viruses to HIV Mono-Infection Through the Pillars of Hercules 2011 ·Current HIV Research ·D Gotti, Emanuele Focà, Laura Albini, (unknown), Andrea Vavassori, Eugenia Quirós-Roldán, Carlo Torti	2
13	A Randomized, Pilot Trial to Evaluate Glomerular Filtration Rate by Creatinine or Cystatin C in Naive HIV-Infected Patients After Tenofovir/Emtricitabine in Combination With Atazanavir/Ritonavir or Efavirenz 2011 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Laura Albini, Bruno Mario Cesana, Davide Motta, Emanuele Focà, D Gotti, Alessandra Calabresi, Ilaria Izzo, Rita Bellagamba, (unknown), Pasquale Narciso, Laura Sighinolfi, Paolo Maggi, Eugenia Quirós-Roldán, Luigi Manili, Giovanni Guaraldi, Giuseppe Lapadula, Carlo Torti	34
14	Evaluation of Liver Fibrosis: Concordance Analysis between Noninvasive Scores (APRI and FIB-4) Evolution and Predictors in a Cohort of HIV-Infected Patients without Hepatitis C and B Infection 2011 ·Clinical Infectious Diseases ·(unknown), Emanuele Focà, D Gotti, Nicoletta Ladisa, Gioacchino Angarano, Laura Albini, (unknown), G. Carosi, Eugenia Quirós-Roldán, Carlo Torti	64
15	Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy 2011 ·Journal of Antimicrobial Chemotherapy ·J. Pavie, Raphaël Porcher, Carlo Torti, J. Medraño, Antonella Castagna, Nadia Valin, Stefano Rusconi, Adriana Ammassari, Jade Ghosn, Constance Delaugerre, Jean‐Michel Molina, (unknown), Marco Franzetti, (unknown), Patrizia Lorenzini, Giampiero Carosi, Laura Albini, (unknown), Eugenia Quirós-Roldán, Filippo Castelnuovo, A. Rachline	26
16	The evolving burden of HIV infection compared with other chronic diseases in northern Italy* 2010 ·HIV Medicine ·Michele Magoni, Carmelo Scarcella, (unknown), Fulvio Lonati, Giampiero Carosi, Filippo Castelnuovo, Eugenia Quirós-Roldán, Laura Albini, Nicola Gennaro, David Bishai, Andrea Tramarin, Carlo Torti	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact